We are live on ! Find out more
ML

McAdam LLC Portfolio holdings

AUM $2.22B
1-Year Est. Return 16.98%
This Fund
S&P 500
This Quarter Est. Return
+1.6%
1 Year Est. Return
+16.98%
3 Year Est. Return
+46.26%
5 Year Est. Return
+42.13%
10 Year Est. Return
–
AUM
$246M
AUM Growth
+$27.9M
Cap. Flow
+$24.9M
Cap. Flow %
10.14%
Top 10 Hldgs %
64.81%
Holding
904
New
61
Increased
149
Reduced
132
Closed
202

Top Buys

1
FNDX icon
Schwab Fundamental US Large Company Index ETF
FNDX
+$2.75M
2
SCHX icon
Schwab US Large- Cap ETF
SCHX
+$2.47M
3
SCHZ icon
Schwab US Aggregate Bond ETF
SCHZ
+$2.28M
4
SCHF icon
Schwab International Equity ETF
SCHF
+$2M
5
SCHG icon
Schwab US Large-Cap Growth ETF
SCHG
+$1.99M

Top Sells

1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$131K
2
EZU icon
iShare MSCI Eurozone ETF
EZU
+$113K
3
VUG icon
Vanguard Growth ETF
VUG
+$104K
4
VT icon
Vanguard Total World Stock ETF
VT
+$103K
5
RPV icon
Invesco S&P 500 Pure Value ETF
RPV
+$97.9K

Sector Composition

1 Technology 1.2%
2 Healthcare 1.18%
3 Consumer Discretionary 0.7%
4 Communication Services 0.61%
5 Industrials 0.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENB icon
226
Enbridge
ENB
$124B
$22K 0.01%
606
– –
GLW icon
227
Corning
GLW
$135B
$22K 0.01%
811
– –
SNAP icon
228
Snap
SNAP
$7.52B
$22K 0.01%
1,647
– –
EXC icon
229
Exelon
EXC
$47.7B
$21K 0.01%
701
-2,503
-78% -$71.7K
HUM icon
230
Humana
HUM
$47.5B
$21K 0.01%
71
-5
-7% -$1.46K
IYY icon
231
iShares Dow Jones US ETF
IYY
$2.96B
$21K 0.01%
310
+60
+24% +$4.07K
NTAP icon
232
NetApp
NTAP
$31.9B
$21K 0.01%
270
– –
RWR icon
233
State Street SPDR Dow Jones REIT ETF
RWR
$1.89B
$21K 0.01%
221
– –
SBUX icon
234
Starbucks
SBUX
$121B
$21K 0.01%
430
– –
SPHB icon
235
Invesco S&P 500 High Beta ETF
SPHB
$977M
$21K 0.01%
496
+4
+0.8% +$174
TXN icon
236
Texas Instruments
TXN
$261B
$21K 0.01%
186
-48
-21% -$5.19K
USIG icon
237
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.4B
$21K 0.01%
400
– –
APC
238
DELISTED
Anadarko Petroleum
APC
$21K 0.01%
288
– –
TFCF
239
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$21K 0.01%
432
– –
BMRN icon
240
BioMarin Pharmaceuticals
BMRN
$11.6B
$20K 0.01%
210
– –
BMY icon
241
Bristol-Myers Squibb
BMY
$125B
$20K 0.01%
363
+50
+16% +$2.7K
DFE icon
242
WisdomTree Europe SmallCap Dividend Fund
DFE
$163M
$20K 0.01%
300
– –
MDY icon
243
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
$20K 0.01%
55
+11
+25% +$3.87K
MET icon
244
MetLife
MET
$60.6B
$20K 0.01%
469
– –
SHW icon
245
Sherwin-Williams
SHW
$82.3B
$20K 0.01%
150
– –
AIG icon
246
American International
AIG
$42.7B
$19K 0.01%
360
+101
+39% +$5.47K
ISCB icon
247
iShares Morningstar Small-Cap ETF
ISCB
$283M
$19K 0.01%
420
– –
PDP icon
248
Invesco Dorsey Wright Momentum ETF
PDP
$1.48B
$19K 0.01%
340
– –
RSPT icon
249
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.4B
$19K 0.01%
1,220
– –
RWK icon
250
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.3B
$19K 0.01%
305
– –
8 9
10
11 12

Similar funds

VWM
Venturi Wealth Management Austin, Texas $2.22B AUM 24.65% 1-Year Est. Return
NLGIA
Nippon Life Global Investors Americas New York $2.22B AUM 30.05% 1-Year Est. Return
IFA
Index Fund Advisors Irvine, California $2.22B AUM 20.66% 1-Year Est. Return
DPCM
Darlington Partners Capital Management Greenbrae, California $2.23B AUM 16.2% 1-Year Est. Return
BOI
Bank of Italy Rome, Italy $2.21B AUM 9.01% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.23B AUM 15% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.23B AUM 15.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

McAdam LLC's Q2 2018 Portfolio in Review

As of Q2 2018, McAdam LLC held 904 positions worth $246M, up 13% from $218M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

McAdam LLC deployed $24.9M of net new capital in Q2 2018, opening 61 new positions and adding to 149 existing holdings. Its largest new stake was BrightSpire Capital: 7,203 shares worth $149K.

By sector, the portfolio is most concentrated in Technology at 1.2% of assets, down from 1.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $131K trimmed.

  • McAdam LLC's largest Q2 2018 buy was BrightSpire Capital: 7,203 shares worth $149K.
  • McAdam LLC added most to Schwab Fundamental US Large Company Index ETF in Q2 2018, an estimated $2.75M increase.
  • McAdam LLC's biggest Q2 2018 reduction was Vertex Pharmaceuticals, cutting an estimated $131K.
  • McAdam LLC fully exited ProShares Short S&P500 in Q2 2018, selling an estimated $76K.
  • McAdam LLC's ten largest holdings make up 65% of its $246M portfolio in Q2 2018.
  • McAdam LLC opened 61 new positions and closed 202 in Q2 2018.
  • McAdam LLC's portfolio value rose 13% quarter-over-quarter to $246M.

Based on McAdam LLC's 13F filing for Q2 2018, filed 22 Aug 2018.